Top 10 Under 40
Biopharma Research and Businesses Benefit from Contributions of Emerging Leaders
Mass Spec Is Being Souped Up to Help It Keep Up
A Few Modifications Might Enhance Performance
Breaking NGS Ground
CMS Final Coverage Determination Promotes Sequencing-Based Testing for Advanced Cancer
GEN Roundup: Bioprocess Filtration Adjusts for Smooth Flows
Avoiding Downstream Production Snarls Is an Exercise in Traffic Management
For full access to this article login to GEN Select now.
Hope Springs Pluripotent—within Bounds
Therapeutics Based on Induced Pluripotent Stem Cells Are Nearing Clinical Trials
- For those who advocate therapeutic applications of induced pluripotent stem cells (iPSCs), these are heady times. New funding flows are opening, regulations are undergoing some “streamlining,” and clinical trials are being planned. Taken together, these developments justify optimism. Might they even inspire giddiness? Apparently not, if we may ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.